glp 1 cons GLP-1 Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH The promise and peril of
Description
Though scenarios (1) and (2) require the same budget, our analysis suggests that (2) reduces national obesity and mortality to a much greater degree
10.1093/eurheartj/ehae508 88
10.1016/j.kint.2022.08.012 [DOI] [PubMed] [Google Scholar] 12
Juliette Cubanski, Tricia Neuman, and Nolan Sroczynski are with KFF
While direct evidence for brain fog improvement is lacking, several mechanisms suggest GLP-1 medications could theoretically influence cognitive function
Pros: Long track record of safety
